gadolinium has been researched along with organophosphonates in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.53) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 10 (52.63) | 29.6817 |
2010's | 6 (31.58) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adzamli, IK; Blau, M | 1 |
Adzamli, IK; Blau, M; Gries, H; Johnson, D | 1 |
Chiu, NY; Coopermann, BS | 1 |
Aime, S; Botta, M; Gianolio, E; Giovenzana, GB; Lowe, MP; Pagliarin, R; Palmisano, G; Parker, D; Sisti, M; Terreno, E | 1 |
Borel, A; Helm, L; Merbach, AE | 1 |
Caravan, P; Greenfield, MT; Li, X; Sherry, AD | 1 |
Hancox, JC; Zhang, YH | 1 |
Balogh, E; de Blas, A; Djanashvili, K; Mato-Iglesias, M; Muller, RN; Peters, JA; Platas-Iglesias, C; Rodríguez-Blas, T; Tóth, E; Vander Elst, L | 1 |
Balogh, E; de Blas, A; Djanashvili, K; Mato-Iglesias, M; Peters, JA; Platas-Iglesias, C; Rodríguez-Blas, T; Tóth, E | 1 |
Binnemans, K; Helm, L; Hermann, P; Kotek, J; Lebdusková, P; Lukes, I; Merbach, AE; Rudovský, J; Tóth, E | 1 |
Aime, S; Barge, A; Botta, M; Lovazzano, C; Milone, L; Tei, L | 1 |
Hermann, P; Kotek, J; Kubícek, V; Lukes, I; Muller, RN; Peters, JA; Vander Elst, L; Vitha, T | 1 |
Dutta, A; Kaul, A; Mishra, AK; Ojha, H; Shukla, G; Srivastava, P; Srivastava, R; Tiwari, AK | 1 |
Černý, J; Hermann, P; Herynek, V; Jendelová, P; Jirák, D; Kapcalová, M; Kotek, J; Kubíček, V; Lukeš, I; Řehoř, I; Vilímová, V | 1 |
Angelovski, G; Engelmann, J; Logothetis, NK; Natrajan, LS; Placidi, MP | 1 |
Duncan, AK; Klemm, PJ; Landry, CC; Raymond, KN | 1 |
Angelovski, G; Baranyai, Z; Botta, M; Hagberg, GE; Kálmán, FK; Krenzer, A; Logothetis, NK; Placidi, MP; Rogerson, AK; Tóth, I | 1 |
Cheng, Z; Tsourkas, A | 1 |
Abada, S; Botta, M; Cassino, C; Charbonnière, LJ; Choquet, P; Elhabiri, M; Esteban-Gómez, D; Nonat, A; Platas-Iglesias, C; Sy, M | 1 |
19 other study(ies) available for gadolinium and organophosphonates
Article | Year |
---|---|
Phosphonate-modified GdDTPA complexes. I. NMRD study of the solution behavior of new tissue-specific contrast agents.
Topics: Contrast Media; Diphosphonates; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organophosphonates; Pamidronate; Pentetic Acid | 1991 |
Development of phosphonate derivatives of gadolinium chelates for NMR imaging of calcified soft tissues.
Topics: Animals; Bone and Bones; Calcinosis; Contrast Media; Gadolinium; Ligands; Magnetic Resonance Imaging; Organometallic Compounds; Organophosphonates; Rats; Structure-Activity Relationship; Tissue Distribution | 1989 |
Yeast inorganic pyrophosphatase. II. Magnetic resonance and steady-state kinetic studies of metal ion and pyrophosphate analog binding.
Topics: Binding Sites; Binding, Competitive; Calcium; Cations, Divalent; Diphosphates; Electron Spin Resonance Spectroscopy; Gadolinium; Kinetics; Magnesium; Magnetic Resonance Spectroscopy; Manganese; Methanol; Organophosphonates; Osmolar Concentration; Pyrophosphatases; Saccharomyces cerevisiae; Structure-Activity Relationship; Temperature; Zinc | 1973 |
Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI.
Topics: beta-Cyclodextrins; Contrast Media; Cyclodextrins; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Luminescent Measurements; Magnetic Resonance Imaging; Metalloproteins; Molecular Structure; Organophosphonates; Protein Binding; Serum Albumin; Temperature; Water | 2000 |
Molecular dynamics simulations of MRI-relevant GdIII chelates: direct access to outer-sphere relaxivity.
Topics: Amines; Carboxylic Acids; Chelating Agents; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Models, Molecular; Molecular Conformation; Molecular Structure; Organophosphonates; Structure-Activity Relationship | 2001 |
The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities.
Topics: Algorithms; Binding Sites; Chemical Phenomena; Chemistry, Physical; Dansyl Compounds; Fatty Acids; Fluorescence; Gadolinium; Humans; Ligands; Models, Molecular; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Proteins; Sarcosine; Serum Albumin; Water | 2001 |
A novel, voltage-dependent nonselective cation current activated by insulin in guinea pig isolated ventricular myocytes.
Topics: Animals; Cations; Cesium; Diglycerides; Dose-Response Relationship, Drug; Estrenes; Flufenamic Acid; Gadolinium; Guinea Pigs; Imidazoles; Insulin; Ion Channels; Lithium; Male; Membrane Potentials; Myocytes, Cardiac; Naphthalenes; Organophosphonates; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Potassium; Protein-Tyrosine Kinases; Pyrrolidinones; Sodium; Type C Phospholipases | 2003 |
The highest water exchange rate ever measured for a Gd(III) chelate.
Topics: Chelating Agents; Electron Spin Resonance Spectroscopy; Gadolinium; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphonates; Oxygen; Spectrophotometry, Ultraviolet; Water | 2005 |
Pyridine- and phosphonate-containing ligands for stable Ln complexation. Extremely fast water exchange on the Gd(III) chelates.
Topics: Chelating Agents; Europium; Gadolinium; Lanthanum; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Organophosphonates; Pyridines; Spectrophotometry | 2006 |
Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphonates; Solutions; Water | 2007 |
1H and 17O NMR relaxometric study in aqueous solution of Gd(III) complexes of EGTA-like derivatives bearing methylenephosphonic groups.
Topics: Contrast Media; Egtazic Acid; Gadolinium; Kinetics; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organophosphonates; Oxygen Isotopes; Solutions; Water | 2008 |
Gd(iii) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(iii) complexes for imaging and radiotherapy of calcified tissues.
Topics: Bone and Bones; Calcinosis; Chelating Agents; Contrast Media; Crystallography, X-Ray; Diagnostic Imaging; Durapatite; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Molecular Structure; Organophosphonates; Radiography | 2009 |
Quantitative structure-property relationship (correlation analysis) of phosphonic acid-based chelates in design of MRI contrast agent.
Topics: Chelating Agents; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Models, Statistical; Organophosphonates; Quantitative Structure-Activity Relationship | 2009 |
Phosphonate-titanium dioxide assemblies: platform for multimodal diagnostic-therapeutic nanoprobes.
Topics: Affinity Labels; Animals; Antineoplastic Agents; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Fluorescent Dyes; Gadolinium; HeLa Cells; Humans; Magnetic Resonance Imaging; Mesenchymal Stem Cells; Mice; Microscopy, Fluorescence; Nanoparticles; Organophosphonates; Structure-Activity Relationship; T-Lymphocytes; Titanium; Ultraviolet Rays | 2011 |
An aryl-phosphonate appended macrocyclic platform for lanthanide based bimodal imaging agents.
Topics: 3T3 Cells; Animals; Contrast Media; Europium; Gadolinium; Ligands; Luminescence; Luminescent Agents; Magnetic Resonance Imaging; Mice; Organophosphonates; Terbium | 2011 |
Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents.
Topics: Contrast Media; Gadolinium; Magnetic Resonance Imaging; Microspheres; Organophosphonates; Porosity; Silicon Dioxide | 2012 |
Aryl-phosphonate lanthanide complexes and their fluorinated derivatives: investigation of their unusual relaxometric behavior and potential application as dual frequency 1H/19F MRI probes.
Topics: Fluorine; Gadolinium; Lanthanoid Series Elements; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organophosphonates | 2013 |
Monitoring phospholipase A₂ activity with Gd-encapsulated phospholipid liposomes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Arachidonic Acids; Contrast Media; Drug Compounding; Drug Liberation; Elapidae; Gadolinium; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Organometallic Compounds; Organophosphonates; Permeability; Phosphatidylethanolamines; Phospholipases A2; Polyethylene Glycols | 2014 |
Importance of outer-sphere and aggregation phenomena in the relaxation properties of phosphonated gadolinium complexes with potential applications as MRI contrast agents.
Topics: Animals; Contrast Media; Gadolinium; Kidney; Lanthanoid Series Elements; Liver; Magnetic Resonance Imaging; Mice; Molecular Structure; Organophosphonates; Pyridines | 2015 |